Cargando…
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
SIMPLE SUMMARY: Previously, we demonstrated that qualitative scoring of pancreatic ductal adenocarcinoma (PDAC) tumors on computed tomography (CT) scans (delta) is biologically and clinically relevant, whereby tumors with a conspicuous border (high delta) show more aggressive biology and are associa...
Autores principales: | Zaid, Mohamed, Widmann, Lauren, Dai, Annie, Sun, Kevin, Zhang, Jie, Zhao, Jun, Hurd, Mark W., Varadhachary, Gauri R., Wolff, Robert A., Maitra, Anirban, Katz, Matthew H. G., Herman, Joseph M., Wang, Huamin, Knopp, Michael V., Williams, Terence M., Bhosale, Priya, Tamm, Eric P., Koay, Eugene J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762105/ https://www.ncbi.nlm.nih.gov/pubmed/33291471 http://dx.doi.org/10.3390/cancers12123656 |
Ejemplares similares
-
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
por: Douglas, Julia E., et al.
Publicado: (2022) -
Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018) -
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma
por: Liu, Qingqing, et al.
Publicado: (2017) -
Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
por: Koay, Eugene J., et al.
Publicado: (2019) -
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)